Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2 FY27 revenue INR 21,806 Cr; EBITDA INR 609 Cr; PAT INR 293 Cr
- Mobile volumes stable YoY; H2 volume guidance ~33-34 million excluding Vivo
- Exports ramp-up from Q4; Transsion exports start next fiscal
- IT hardware revenue INR 2,160 Cr; targeting INR 15,000-20,000 Cr in 2 years
- Display and camera modules capacity expansion; display revenue potential INR 6,000-7,000 Cr
- Telecom segment growing; optical transceiver JV with Gemtek to start Q4
- Home appliances and lighting impacted by input cost; margin recovery expected
- Working capital elevated due to PLI receivables; expected release by March
- Capex guidance INR 1,200-1,300 Cr/year; display capex INR 1,000 Cr over 3 years
- Optical transceivers and advanced packaging pursued for AI/data center growth
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 DIXON — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add DIXON to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Dixon Technologies (India) Limited
Important.
The summary above is generated automatically from Dixon Technologies (India) Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.